The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

Several male enhancement dietary supplements have been recalled due to undeclared and potentially harmful ingredients being ...

The FDA has received reports of erectile dysfunction, anxiety, and more after using topical finasteride, a popular hair loss ...

In the first quarter of 2025, the Company completed a public offering of 5.1 million ordinary shares, including the full exercise of the underwriters' overallotment option, at a public offering price ...

These include in-vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) which both involve handling of sperm and eggs (gametes) in the laboratory to form embryos. If there’s more ...

(FAPi)2) has been in-licensed by Telix as part of a portfolio of next-generation therapeutic and diagnostic (“theranostic”) radiopharmaceutical candidates 2. TLX400 has potential clinical utility in ...

UBS (NYSE:UBS) (SWX:UBSN) today published the UBS AG first-quarter 2025 financial report and the 31 March 2025 UBS Group Pillar 3 Report. These reports are available for download on the UBS website.

As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and ...

Net Loss: For the first quarter of 2025, the Company generated a net loss attributable to its shareholders of $19.6 million, ...

But the term became shorthand for a group of milder, related conditions known as ″autism spectrum disorders,” and the number of kids labeled as having some form of autism began ... “There are adverse ...

UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity UbiVac is thrilled to announce the first ...

Psychiatric neurosurgery, originally known as psychosurgery, involves operating on the brain to alter its function. Nastasic ...